Serum Mn-superoxide dismutase in acute myocardial infarction

Clinical Biochemistry

Volumn 30, Issue 7, 1997, Pages 569-571

  Fortunato, Giuliana ^a   Pastinese, Antonella ^a   Intrieri, Mariano ^b   Lofrano, Maria M ^c   Gaeta, Giovanni ^c   Censi, Marcello Bolletti ^c   Boccalatte, Aldo ^c   Salvatore, Francesco ^a   Sacchetti, Lucia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Fisiche Naturali Univ Studi M   (Italy)

^c Azienda Ospedaliera Rilevanza N   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; Q WAVE;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; EVALUATION STUDIES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; STROKE VOLUME; SUPEROXIDE DISMUTASE;

EID: 0030657946     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00103-3     Document Type: Article

References (10)

1. Taniguchi N, Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. In: Advances in Clinical Chemistry, volume 29. (Ed. Spiegel HE) Pp. 1-59. San Diego CA: Academic Press, Inc, 1992.
2. Kawaguchi T, Suzuki K, Matsuda Y, et al. Serum-manganese superoxide dismutase normal values and increased levels in patients with acute myocardial infarction and several malignant diseases determined by an enzyme-linked immunosorbent assay using a monoclonal antibody . J Immunol Meth. 127:1990;249-254.
3. Suzuki K, Kinoshita N, Matsuda Y, et al. Elevation of immunoreactive serum Mn-superoxide dismutase in patients with acute myocardial infarction. Free Radic Res Commun. 15:1992;325-334.
4. Risk stratification and survival after myocardial infarction. N Engl J Med. 309:1983;331-336.
5. St. John Sutton M, Pfeffer MA, Plappert T, et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation. 89:1994;68-75.
6. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA, Guidelines for the management of patients with acute myocardial infarction. JACC. 28:(5):1996;1328-1428.
7. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two years experience with 250 patients. Am J Cardiol. 20:1967;457-464.
8. Nosir YFM, Fioretti PM, Vletter WB, et al. Accurate measurement of left ventricular ejection fraction by tri-dimensional echocardiography. A comparison with radionuclide angiography. Circulation. 94:1996;460-466.
9. Ahnve S, Gilpin E, Henning H, et al. Limitation and advantages of the ejection fraction for defining high risk after acute myocardial infarction. Am J Cardiol. 58:1986;872-878.
10. Galen RS, Gambino SR. Sensitivity, specificity, prevalence and incidence. Galen RS, Gambino SR. Beyond Normality The Predictive Value and Efficiency of Medical Diagnosis . 1977;10-14 Wiley Biomedical Publisher, New York.